Thursday, February 18, 2021
Investor Ideas #Potcasts 532, #Cannabis News and #Stocks on the Move; Interview with Paul Rosen, CEO of 1933 Industries (CSE: $TGIF.C) (OTC: $TGIFF)
Investor Ideas #Potcasts 532, #Cannabis News and #Stocks on the Move; Interview with Paul Rosen, CEO of 1933 Industries (CSE: $TGIF.C) (OTC: $TGIFF)
Delta, Kelowna, BC, February 18, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/021821-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02181TGIF-Interview.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast Investorideas interviews Paul Rosen, CEO of 1933 Industries (CSE: TGIF) (OTC: TGIFF), where we discussed the current trends surrounding the cannabis industry, current investor sentiment, what are the current expectations surrounding regulatory reform in the US and how 1933 Industries\ home market of Nevada is expected to grow and evolve moving forward.
Paul Rosen is a noted career entrepreneur, management consultant and public speaker. Over the last 8 years Paul has become one of the most active entrepreneurs, advisors and investors in the emerging global cannabis industry. Paul Rosen was a co-founder of PharmaCan Capital Corp. (Now Cronos Group Inc.) (NASDAQ: CRON) (TSX: CRON) and served as its first President and CEO. Paul has held board positions with a number of publicly-traded cannabis companies and currently serves as the Executive Chairman of Global Go, a consultancy focused on the global regulated cannabis industry.
Paul has enjoyed a distinguished speaking and media career. He has appeared on/in Bloomberg, CNN, CNBC, Fox Business, BBC Business, Nasdaq TV, Yahoo Finance, The Economist, The Street, Barrons, National Public Radio and Cheddar TV. Paul is a member of the Law Society of Upper Canada and received a B.A. in Economics from Western University in 1985 and an LL.B. from the University of Toronto in 1988.
Since January, cannabis stocks have seen a flourish of positive trading and investor sentiment, in part due to a trend of positive financial results as well as high expectations surrounding the Democratic majority hopefully pushing more cannabis regulatory reform.
When asked about the current optimism surrounding the cannabis industry today Mr. Rosen commented, “my optimism was never misplaced. Cannabis is a young industry that has already gone through operatic cycles of peaks and pull backs which is typically expected of an early stage industry, but what we should say is the “thesis”around Cannabis has only gone in one direction and that’s straight up. We have to separate the day to day fickleness of investor sentiment with what’s actually happening with the economy of cannabis, and what’s happening the economy of cannabis is month after month sales growth, almost without interruption. I think you can look back on those barrish periods and look at them as buying opportunities, I know I did. I never doubted at a macro level that the industry was under any distress, individual companies were under distress, but the industry has been performing even above most optimistic projections.”
Mr Rosen continued, “There is now an almost irrevocable momentum towards cannabis reform at a global level. We’re going to look back at today’s cannabis economy a decade from now and realize how small it still was. The so-called once in a lifetime opportunity is a chance to help build an industry that inevitably is going to attract the attention and potential market weight of big pharma and big CPG, but to be able to build defendable assets before that happens writ large.”
When asked some of the advantages surrounding the US cannabis industry, and specifically Nevada, Mr. Rosen commented, “I like Nevada a lot from the macroeconomic perspective. Nevada has been a market where the cannabis control board has been more discretionary in the granting of licenses and less administrative. So on the supply demand economics it was a limited supply state and when you introduce the velocity of tourism, in a regular pre-COVID economy, it had a remarkable demand. One thing we’ve learned during COVID was that Nevada was not as dependent on the tourism market as we had though, there is a very healthy domestic market there, but once tourism comes back it comes back to supply and demand. Let’s say tourism returns to normal 6 months from now, which is going to more than double the total addressable market, there won’t be a two-times response in available capacity.”
|Mr. Rosen went on to comment on the speculation surrounding legalization in the US saying, “I predict, and I am far from alone in this, this a consensus point of thought leaders in our industry, that we will see a series of incremental congressional initiatives succeed in this congress in the next 24 months before midterms. We all know these acronyms like they’re the names of our pets; the SAFE Act, MORE Act and STATES Act. Exactly which os those congressional initiatives passed first? I hope it’s the SAFE Act, because the banking act would be the most transformative as one single piece of legislation for the development of the industry. Any one of them would have the same effect, it’s just the effect would be more pronounced with SAFE. As to legalization, well it’s coming, but the question is what it’s going to look like? The question to drill down to is where is cannabis going to show up on the Schedule on the controlled substances act? If I could have my druthers I would say deschedule cannabis, take it right out the controlled substances act, pass those legislations and reap the benefits of a dynamic industry that favours nearly every constituency and causes little to no social harm.”
Mr. Rosen went on to discuss the expected clarification from the FDA surrounding the CBD industry in the US, how the WallStreetBets community has recently focussed on the cannabis sector, synthesis versus full and partial spectrum products, the emergence of psychedelics and what investors and consumers should look forward to in the cannabis industry in 2021 and beyond.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Tuesday, February 16, 2021
Investor Ideas #Potcasts 531, #Cannabis News and #Stocks on the Move; (CSE: $IPOT.C) (TSX: $HEXO.TO) (NYSE: $HEXO) (TSXV: $NDVA.V) (TSX: $FAF.TO)
Investor Ideas #Potcasts 531, #Cannabis News and #Stocks on the Move; (CSE: $IPOT.C) (TSX: $HEXO.TO) (NYSE: $HEXO) (TSXV: $NDVA.V) (TSX: $FAF.TO)
Delta, Kelowna, BC, February 16, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/021621-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02161IPOT-HEXO-NDVA-FAF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we will be looking at a few public and private company announcements.
Isracann Biosciences Inc. (CSE: IPOT) (OTC: ISCNF), an Israel-based company focused on becoming a premier low cost, high quality cannabis producer announced that its flagship Hefer Valley-based Ein Hahoresh Farm is in full readiness to commence growing and production activities.
With the phase one 54,000 sq. ft. of greenhouse canopy fully constructed and extensive processing capability in-place, Isracann is moving rapidly towards the commencement of industrial-scale operations aimed at servicing both domestic and European export markets in 2021.
The Ein Hahoresh farm operations and construction teams recently expanded the onsite post-harvest facility in preparation to meet increased demand from regional partners representing both domestic and export market sales opportunities. Subject to final Security and Ministry of Health approvals for the requisite farm operating license, the Company is preparing the property for imminent production activities.
Currently, Isracann and its local consultants have scheduled the commencement of planting for early March to coincide with the start of optimal climatic conditions, subject to the timely receipt of final government approvals.
Isracann COO Matt Chatterton comments, “We are pleased to report that we have concluded every step as outlined by our regional consultants who have brought proven and invaluable experience in working with the Israeli government. Additionally, it should be noted that the various representatives of the ministries involved have been professional, open, and forthright in their dealings with us at all times. Everyone has been working within the context of the global pandemic and we are grateful to all concerned to have achieved so much during what have been extremely trying times. We look forward to reporting on the conclusion of the upcoming inspections and confidently anticipate an exciting period of activity ahead as we continue to build, grow and create value in Israel.”
HEXO Corp. (TSX: HEXO) (NYSE: HEXO) and Zenabis Global Inc. (TSX: ZENA) announced that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which HEXO will acquire, by way of court-approved plan of arrangement under the Business Corporations Act (British Columbia), all of Zenabis’ issued and outstanding common shares in an all-share transaction valued at approximately $235 million. Under the terms of the Arrangement Agreement, Zenabis shareholders will receive 0.01772 of a HEXO common share in exchange for each Zenabis common share held (the “Exchange Ratio”). The Exchange Ratio implies a premium per Zenabis common share of approximately 19% based on the 20-day volume-weighted average price ("VWAP") of Zenabis common shares on TSX and HEXO common shares on TSX as of February 12, 2021. Warrants and incentive securities of Zenabis will be adjusted in accordance with their terms to ultimately become exercisable to receive common shares of HEXO based on the share exchange ratio.
The Transaction was unanimously approved by the board of directors of each of HEXO and Zenabis (in the case of Zenabis’ board of directors, after receiving the unanimous recommendation of a special committee formed for purposes of the Transaction), and Zenabis’ board of directors unanimously recommends that its shareholders vote in favour of the Transaction.
Transaction Highlights
● Strengthened domestic brands: Based on HEXO’s and Zenabis’ most recent interim quarterly financial statements and results, and those of the other top licensed producers in Canada, the combined organization would be a top three licensed producer in terms of combined Canadian recreational cannabis sales.
● Foothold in Europe: The Transaction gives HEXO immediate access to the European medical cannabis market through Zenabis’ local partner, with an established facility in the European Union supplying pharmaceutical products to the European market. The facility also serves as a European Union Good Manufacturing Practice packaging and distribution centre for medical cannabis products produced in Zenabis' Atholville Facility.
● Accretive synergies: HEXO estimates that the combined entity may realize annual synergies of approximately $20 million within one year of close, through cost of goods reductions, additional capacity utilization in HEXO’s Belleville Centre of Excellence and selling, general and administrative savings, which, if realized, should allow HEXO to continue its path towards positive earnings.
● Capacity boost with state-of-the-art cultivation infrastructure: The proposed Transaction would give HEXO access to licensed capacity to produce approximately 111,200 kg of additional high-quality cannabis annually. The Transaction would result in HEXO acquiring two indoor facilities (approximately 635,000 sq. ft.) and access to a 2.1 million sq. ft. greenhouse facility, totalling approximately 2.735 million sq. ft. of near-term cultivation space offering diversified growing and production techniques. This provides a platform for growth and foundation from which to strengthen and diversify our portfolio of brands.
“We're thrilled to welcome the Zenabis team into the HEXO family. Zenabis has built solid relationships and they share HEXO’s vision of bringing exceptional branded cannabis experiences to adults everywhere, in Canada and abroad” said Sebastien St-Louis, CEO and co-founder of HEXO Corp. “We are proceeding with this transaction because we believe it should be accretive for our shareholders, and it also positions HEXO for accelerated domestic and international growth while supporting near-term requirements for additional licensed capacity. HEXO’s growth strategy includes expanding our global presence, and this acquisition is an important step in that direction.”
“This is a compelling combination. Our brands and strains strength across Canada, coupled with our international footprint and state of the art low cost and high quality cultivation facilities complements HEXO’s business, creating an industry leader. Like HEXO, Zenabis believes that the combination should deliver meaningful synergies, a stronger financial position with increased flexibility, and should position the combined company to meet growing consumer demand on a national and international basis. I believe this transaction is beneficial to our shareholders, customers, partners, and employees. We look forward to working closely with HEXO to complete this transaction," added Shai Altman, CEO of Zenabis.
Sundial Growers Inc. (NASDAQ: SNDL), a Canadian licensed producer of recreational cannabis and Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF), a leading Canadian producer of cannabis edibles, announced a $22,000,000 strategic investment into Indiva by Sundial.
The Investment will be completed in the form of a brokered private placement led by ATB Capital Markets Inc. of 25,000,000 common shares of Indiva at a price of $0.44 per Common Share, to raise gross proceeds of $11,000,000, and a non-revolving term loan facility to Indiva in the principal amount of $11,000,000. It is anticipated that Sundial will be the sole subscriber in the Placement. Proceeds to Indiva, net of fees, commissions and expenses are expected to be approximately $20.9 million.
"Sundial is pleased to support the development of Indiva's high-quality products," said Zach George, Chief Executive Officer of Sundial. "This transaction broadens our exposure to the rapidly expanding cannabis edibles category."
Indiva intends to use the net proceeds of the Placement and Term Loan to retire its outstanding debt in full, which includes its demand loan and promissory note, as well as for working capital and other general corporate purposes.
"We are delighted to welcome Sundial as a strategic investor in Indiva," said Niel Marotta, President and Chief Executive Officer of Indiva. "The capital from this $22 million investment significantly improves Indiva's balance sheet, expands our working capital, and provides the resources necessary to support strong growth in our business. Indiva will now have the ability to make additional capital investments, primarily into automation, which will drive higher throughput and profitability, while ensuring our product quality maintains the best-in-class standard our customers and clients depend upon. Indiva's bolstered financial strength will ensure we can defend our market share position as a top edibles producer in Canada, and continue to bring new and innovative cannabis products to of-age Canadians."
Sundial and Indiva intend to complete the Investment on or about February 23, 2021, subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange.
The securities issued under the Placement will be subject to a statutory hold period of four months and one day following the closing of the Placement.
Indiva has agreed to: (a) pay to ATB a cash commission equal to 3.0% of the aggregate gross proceeds received by Indiva from the Placement from Sundial and 6.0% of the aggregate gross proceeds received by Indiva from the Placement from subscribers other than Sundial, if applicable; and (b) pay to the Agent a cash commission equal to 2.0% of the total loan commitment under the Term Loan.
Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF), a leading cannabis retailer with a proprietary e-commerce and digital retail platform, today announced that it has submitted an initial application to list its common shares on the Nasdaq Stock Market.
The anticipated Nasdaq listing is part of Fire & Flower's growth strategy which is focused on expanding its brand to markets outside of Canada. The Company anticipates that the Nasdaq listing will assist in attracting retail and institutional investors interested in Fire & Flower's international growth ambitions as well as provide the Company with increased access to strategic partners, deal-flow and value creation opportunities.
Trevor Fencott, Chief Executive Officer of Fire & Flower, commented, "We are firmly committed to building Fire & Flower into one of the leading cannabis retailers in the world. Our ability to deliver a superior cannabis product and customer experience, along with our cutting-edge technology, has driven our success in Canada and strongly positions our Company for continued expansion in new high-growth markets."
Fencott continued, "Our focus on building a leadership position within the cannabis industry goes hand in hand with driving increased value for our shareholders. This application to list on Nasdaq is a major step forward in expanding our shareholder base in the United States. We will continue to pursue domestic and international opportunities for accelerated growth in the years ahead and look forward to updating our broadening shareholder base as we move ahead."
Fire & Flower will continue to be listed on the Toronto Stock Exchange under the symbol "FAF". The listing of the Company's common shares on Nasdaq remains subject to the review and approval of the Company's listing application and the satisfaction of all applicable listing and regulatory requirements. The Company has retained Dentons as legal counsel in connection with the application to list on Nasdaq.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear the investor ideas potcast on Spotify
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)